bioRASI leverages RAS' expertise and infrastructure by providing contract research organization (CRO) services to its Collaborative R&D™ clients. Specifically, bioRASI offers drugs, biologicals, and medical devices sponsors the entire range of global CRO services, from discovery through clinical research and development. bioRASI also provides clients with a unique highly value-added offering: Rapid Prototyping™. bioRASI is a strategic initiative of the Russian Academy of Sciences (RAS), responsible for commercializing RAS' bio-sciences and clinical resources. By creating Collaborative R&D™ relations with clients/partners around the world, bioRASI significantly accelerates the development and implementation of novel therapeutics and diagnostics.